Dialysis-functionalized microfluidic platform for in situ formation of purified liposomes.
Colloids Surf B Biointerfaces
; 236: 113829, 2024 Apr.
Article
en En
| MEDLINE
| ID: mdl-38430829
ABSTRACT
Continuous-flow microfluidic devices have been extensively used for producing liposomes due to their high controllability and efficient synthesis processes. However, traditional methods for liposome purification, such as dialysis, gel chromatography, and ultrafiltration, are incompatible with microfluidic devices, which would dramatically restrict the efficiency of liposome synthesis. In this study, we developed a dialysis-functionalized microfluidic platform (DFMP) for in situ formation of purified drug-loaded liposomes. The device was successfully fabricated by using a high-resolution projection micro stereolithography (PµSL) 3D printer. The integrated DFMP consists of a microfluidic mixing unit, a microfluidic dialysis unit, and a dialysis membrane, enabling the liposome preparation and purification in one device. The purified ICG-loaded liposomes prepared by DFMP had a smaller size (264.01±5.34â¯nm to 173.93±10.71â¯nm) and a higher encapsulation efficiency (EE) (43.53±0.07% to 46.07±0.67%). In vivo photoacoustic (PA) imaging experiment demonstrated that ICG-loaded liposomes purified with microfluidic dialysis exhibited a stronger penetration and accumulation (2-3 folds) in tumor sites. This work provides a new strategy for one-step production of purified drug-loaded liposomes.
Palabras clave
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Microfluídica
/
Liposomas
Idioma:
En
Año:
2024
Tipo del documento:
Article